These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32825305)

  • 21. Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.
    Farouk AE; Baig MH; Khan MI; Park T; Alotaibi SS; Dong JJ
    Saudi J Biol Sci; 2021 Jun; 28(6):3262-3269. PubMed ID: 33654454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates.
    Damas J; Hughes GM; Keough KC; Painter CA; Persky NS; Corbo M; Hiller M; Koepfli KP; Pfenning AR; Zhao H; Genereux DP; Swofford R; Pollard KS; Ryder OA; Nweeia MT; Lindblad-Toh K; Teeling EC; Karlsson EK; Lewin HA
    Proc Natl Acad Sci U S A; 2020 Sep; 117(36):22311-22322. PubMed ID: 32826334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility.
    Ma C; Gong C
    J Med Virol; 2021 Jul; 93(7):4469-4479. PubMed ID: 33755203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.
    Anand SP; Chen Y; Prévost J; Gasser R; Beaudoin-Bussières G; Abrams CF; Pazgier M; Finzi A
    Viruses; 2020 Sep; 12(10):. PubMed ID: 33003587
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Penta-peptide ATN-161 based neutralization mechanism of SARS-CoV-2 spike protein.
    Rabbani G; Ahn SN; Kwon H; Ahmad K; Choi I
    Biochem Biophys Rep; 2021 Dec; 28():101170. PubMed ID: 34778573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modeling SARS-CoV-2 spike/ACE2 protein-protein interactions for predicting the binding affinity of new spike variants for ACE2, and novel ACE2 structurally related human protein targets, for COVID-19 handling in the 3PM context.
    Tragni V; Preziusi F; Laera L; Onofrio A; Mercurio I; Todisco S; Volpicella M; De Grassi A; Pierri CL
    EPMA J; 2022 Mar; 13(1):149-175. PubMed ID: 35013687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
    Lata S; Akif M
    J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
    Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
    Elife; 2021 Aug; 10():. PubMed ID: 34435953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variations in cell-surface ACE2 levels alter direct binding of SARS-CoV-2 Spike protein and viral infectivity: Implications for measuring Spike protein interactions with animal ACE2 orthologs.
    Kazemi S; López-Muñoz AD; Hollý J; Jin L; Yewdell JW; Dolan BP
    bioRxiv; 2021 Oct; ():. PubMed ID: 34729559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
    Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
    Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
    Wan Y; Shang J; Graham R; Baric RS; Li F
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variants in ACE2; potential influences on virus infection and COVID-19 severity.
    Bakhshandeh B; Sorboni SG; Javanmard AR; Mottaghi SS; Mehrabi MR; Sorouri F; Abbasi A; Jahanafrooz Z
    Infect Genet Evol; 2021 Jun; 90():104773. PubMed ID: 33607284
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lapaillerie D; Charlier C; Fernandes HS; Sousa SF; Lesbats P; Weigel P; Favereaux A; Guyonnet-Duperat V; Parissi V
    Viruses; 2021 Feb; 13(3):. PubMed ID: 33669132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elucidating Interactions Between SARS-CoV-2 Trimeric Spike Protein and ACE2 Using Homology Modeling and Molecular Dynamics Simulations.
    Sakkiah S; Guo W; Pan B; Ji Z; Yavas G; Azevedo M; Hawes J; Patterson TA; Hong H
    Front Chem; 2020; 8():622632. PubMed ID: 33469527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
    Hussain M; Jabeen N; Raza F; Shabbir S; Baig AA; Amanullah A; Aziz B
    J Med Virol; 2020 Sep; 92(9):1580-1586. PubMed ID: 32249956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-based virtual screening and molecular docking of drugs against the SARS-CoV-2 spike protein-ACE2 receptor complex.
    Ahmad I; Ali M; Ali R; Nawaz N; G Patching S
    Pak J Pharm Sci; 2022 Nov; 35(6):1531-1538. PubMed ID: 36789812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High activity of an affinity-matured ACE2 decoy against Omicron SARS-CoV-2 and pre-emergent coronaviruses.
    Sims JJ; Lian S; Meggersee RL; Kasimsetty A; Wilson JM
    PLoS One; 2022; 17(8):e0271359. PubMed ID: 36006993
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
    Othman H; Bouslama Z; Brandenburg JT; da Rocha J; Hamdi Y; Ghedira K; Srairi-Abid N; Hazelhurst S
    Biochem Biophys Res Commun; 2020 Jun; 527(3):702-708. PubMed ID: 32410735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins.
    Conceicao C; Thakur N; Human S; Kelly JT; Logan L; Bialy D; Bhat S; Stevenson-Leggett P; Zagrajek AK; Hollinghurst P; Varga M; Tsirigoti C; Tully M; Chiu C; Moffat K; Silesian AP; Hammond JA; Maier HJ; Bickerton E; Shelton H; Dietrich I; Graham SC; Bailey D
    PLoS Biol; 2020 Dec; 18(12):e3001016. PubMed ID: 33347434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.